HUP0100352A2 - Mycobacterium vaccaeből származó kompozíciók és eljárások ezek alkalmazására - Google Patents
Mycobacterium vaccaeből származó kompozíciók és eljárások ezek alkalmazásáraInfo
- Publication number
- HUP0100352A2 HUP0100352A2 HU0100352A HUP0100352A HUP0100352A2 HU P0100352 A2 HUP0100352 A2 HU P0100352A2 HU 0100352 A HU0100352 A HU 0100352A HU P0100352 A HUP0100352 A HU P0100352A HU P0100352 A2 HUP0100352 A2 HU P0100352A2
- Authority
- HU
- Hungary
- Prior art keywords
- vaccae
- methods
- depleted
- delipidated
- mycobacterium vaccae
- Prior art date
Links
- 241000187644 Mycobacterium vaccae Species 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 3
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 abstract 2
- 229930186217 Glycolipid Natural products 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 abstract 1
- 229920000189 Arabinogalactan Polymers 0.000 abstract 1
- 239000001904 Arabinogalactan Substances 0.000 abstract 1
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 235000019312 arabinogalactan Nutrition 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 239000000706 filtrate Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 208000026278 immune system disease Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99662497A | 1997-12-23 | 1997-12-23 | |
| US08/997,362 US5985287A (en) | 1996-08-29 | 1997-12-23 | Compounds and methods for treatment and diagnosis of mycobacterial infections |
| US08/997,080 US5968524A (en) | 1997-12-23 | 1997-12-23 | Methods and compounds for the treatment of immunologically-mediated psoriasis |
| US09/095,855 US6160093A (en) | 1996-08-29 | 1998-06-11 | Compounds and methods for treatment and diagnosis of mycobacterial infections |
| US15618198A | 1998-09-17 | 1998-09-17 | |
| US09/205,426 US6406704B1 (en) | 1996-08-29 | 1998-12-04 | Compounds and methods for treatment and diagnosis of mycobacterial infections |
| PCT/NZ1998/000189 WO1999032634A2 (en) | 1997-12-23 | 1998-12-23 | Compositions derived from mycobacterium vaccae and methods for their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0100352A2 true HUP0100352A2 (hu) | 2001-06-28 |
Family
ID=27557521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0100352A HUP0100352A2 (hu) | 1997-12-23 | 1998-12-23 | Mycobacterium vaccaeből származó kompozíciók és eljárások ezek alkalmazására |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1044273A2 (tr) |
| JP (1) | JP2002514385A (tr) |
| CN (1) | CN1294632A (tr) |
| AU (1) | AU746311B2 (tr) |
| BR (1) | BR9814432A (tr) |
| CA (1) | CA2315539A1 (tr) |
| HU (1) | HUP0100352A2 (tr) |
| ID (1) | ID26327A (tr) |
| IL (1) | IL136821A0 (tr) |
| MX (1) | MXPA00006168A (tr) |
| NO (1) | NO20003261L (tr) |
| NZ (1) | NZ505834A (tr) |
| PL (1) | PL341697A1 (tr) |
| TR (1) | TR200001948T2 (tr) |
| WO (1) | WO1999032634A2 (tr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6569436B1 (en) | 1998-10-05 | 2003-05-27 | The Malaghan Institute Of Medical Research | Method of using a vaccine |
| JP4415200B2 (ja) * | 1999-01-29 | 2010-02-17 | 大塚製薬株式会社 | 遅発育性抗酸菌ポリペプチド |
| GB9903539D0 (en) | 1999-02-16 | 1999-04-07 | Stanford Rook Ltd | Therapy using M.Vaccae |
| US6350457B1 (en) * | 1999-06-02 | 2002-02-26 | Genesis Research & Development Corporation Limited | Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae |
| BR0012740A (pt) * | 1999-07-12 | 2002-05-28 | Genesis Res & Dev Corp Ltd | Compostos para tratamento de distúrbios do sistema infeccioso e imune e métodos para seu emprego |
| US7217554B2 (en) | 1999-08-31 | 2007-05-15 | Novozymes A/S | Proteases and variants thereof |
| DE10082576D2 (de) * | 1999-08-31 | 2002-12-19 | Michael Niederweis | Verfahren zur Herstellung eines Kanalbildenden Proteins |
| EP2336331A1 (en) * | 1999-08-31 | 2011-06-22 | Novozymes A/S | Novel proteases and variants thereof |
| US6361776B1 (en) * | 1999-12-06 | 2002-03-26 | Genesis Research & Development Corp. Ltd. | Compounds isolated from M. vaccae and their use in modulation of immune responses |
| US20030108527A1 (en) * | 1999-12-28 | 2003-06-12 | Tsukasa Seya | Maturation-promoting agent for immature dendrtic cells |
| AUPQ761200A0 (en) * | 2000-05-19 | 2000-06-15 | Hunter Immunology Limited | Compositions and methods for treatment of mucosal infections |
| AU2002309857A1 (en) * | 2001-05-11 | 2002-12-03 | Corixa Corporation | Vaccines for the treatment of autoimmune disease |
| US20030147861A1 (en) * | 2001-07-26 | 2003-08-07 | Genesis Research And Development Corporation Limited | Compounds and methods for the modulation of immune responses |
| WO2003049751A1 (en) * | 2001-12-10 | 2003-06-19 | Bakulesh Mafatlal Khamar | The process of manufacturing a pharmaceutical composition useful for management of cancer |
| GB0303507D0 (en) * | 2003-02-14 | 2003-03-19 | Novartis Ag | Organic compounds |
| SG11201605595YA (en) * | 2014-01-09 | 2016-08-30 | Transgene Sa | Fusion of heterooligomeric mycobacterial antigens |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8919321D0 (en) * | 1989-08-25 | 1989-10-11 | Univ London | Treatment of chronic inflammatory conditions |
| GB9203814D0 (en) * | 1992-02-21 | 1992-04-08 | Univ London | Treatment of long term auto-immune conditions |
| US6284255B1 (en) * | 1996-08-29 | 2001-09-04 | Genesis Research & Development Corporation Limited | Compounds and methods for treatment and diagnosis of mycobacterial infections |
-
1998
- 1998-12-23 IL IL13682198A patent/IL136821A0/xx unknown
- 1998-12-23 PL PL98341697A patent/PL341697A1/xx unknown
- 1998-12-23 NZ NZ505834A patent/NZ505834A/xx unknown
- 1998-12-23 EP EP98963665A patent/EP1044273A2/en not_active Withdrawn
- 1998-12-23 TR TR2000/01948T patent/TR200001948T2/tr unknown
- 1998-12-23 AU AU18936/99A patent/AU746311B2/en not_active Ceased
- 1998-12-23 MX MXPA00006168A patent/MXPA00006168A/es unknown
- 1998-12-23 WO PCT/NZ1998/000189 patent/WO1999032634A2/en not_active Application Discontinuation
- 1998-12-23 JP JP2000525553A patent/JP2002514385A/ja active Pending
- 1998-12-23 HU HU0100352A patent/HUP0100352A2/hu unknown
- 1998-12-23 ID IDW20001433A patent/ID26327A/id unknown
- 1998-12-23 CA CA002315539A patent/CA2315539A1/en not_active Abandoned
- 1998-12-23 BR BR9814432-4A patent/BR9814432A/pt not_active IP Right Cessation
- 1998-12-23 CN CN98813781A patent/CN1294632A/zh active Pending
-
2000
- 2000-06-22 NO NO20003261A patent/NO20003261L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002514385A (ja) | 2002-05-21 |
| NO20003261D0 (no) | 2000-06-22 |
| TR200001948T2 (tr) | 2001-02-21 |
| EP1044273A2 (en) | 2000-10-18 |
| AU1893699A (en) | 1999-07-12 |
| PL341697A1 (en) | 2001-04-23 |
| CA2315539A1 (en) | 1999-07-01 |
| IL136821A0 (en) | 2001-06-14 |
| AU746311B2 (en) | 2002-04-18 |
| BR9814432A (pt) | 2000-10-10 |
| NO20003261L (no) | 2000-08-22 |
| MXPA00006168A (es) | 2005-02-24 |
| WO1999032634A3 (en) | 1999-12-02 |
| WO1999032634A2 (en) | 1999-07-01 |
| NZ505834A (en) | 2002-12-20 |
| ID26327A (id) | 2000-12-14 |
| CN1294632A (zh) | 2001-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0100352A2 (hu) | Mycobacterium vaccaeből származó kompozíciók és eljárások ezek alkalmazására | |
| ATE314095T1 (de) | Virusähnliche partikel zur induktion von autoantikörpern | |
| MXPA01003557A (es) | Secuencias genomicas de neisseria y metodos para su uso. | |
| MXPA01011047A (es) | Secuencias genomicas de neisseria y metodos para su uso. | |
| WO1999051748A3 (en) | Fusion proteins of mycobacterium tuberculosis antigens and their uses | |
| WO2004047728A3 (en) | Compositions and methods for the treatment of immune related diseases | |
| WO2004039956A3 (en) | Compositions and methods for the treatment of immune related diseases | |
| IL130931A0 (en) | Small molecules useful in the treatment of inflammatory disease | |
| PL332694A1 (en) | Purine l-nucleosides, their analoques and their application | |
| NZ532665A (en) | Neisseria meningitidis antigens and compositions | |
| ATE464910T1 (de) | Humane cd80-mutante und zusammensetzungen und methoden zu deren herstellung und verwendung | |
| GB2355983B (en) | Method for producing or enhancing a T-cell response against a target cell using a complex comprising an HLA class 1 molecule and an attaching means | |
| WO1999059617A3 (en) | Immunoregulator | |
| WO2005030136A3 (en) | Tumor vaccine | |
| WO2004024072A3 (en) | Novel compositions and methods for the treatment of immune related diseases | |
| DE59708495D1 (de) | Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung | |
| WO2000027429A3 (en) | Vaccine against papillomatous digital dermatitis (pdd) | |
| EP1072607A3 (en) | Purine L-nucleosides, analogs and uses therof | |
| DE60134408D1 (de) | Für akzessorische hiv proteine kodierende dna impfstoffe | |
| WO2004041192A3 (en) | Panels of molecular targets differentially expressed during cd8+ t-cell priming | |
| AU7079300A (en) | Compositions and methods for the treatment of immune related diseases | |
| WO2004003153A3 (en) | Live replicating spumavirus vector | |
| WO2001051649A3 (en) | Identification of virulence determinants | |
| EP1637166A3 (en) | Virus-like particles for the induction of autoantibodies |